ClinicalTrials.govcontrolled
A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine
ClinicalTrials.gov study NCT05458011. IPD Sharing: YES. Countries: 1. Publications: 0.
ShareScore
32/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 16
- Harmonization
- 8
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 4